CRSP-4.51%14.0%
NTLA+26.97%13.0%
BEAM+62.60%11.0%
PRME-9.81%9.0%
VERV0.00%8.0%
CRBU+11.49%6.0%
RCKT+32.59%6.0%
EDIT+7.84%5.0%
MGX-42.99%5.0%
SGMO0.00%5.0%
SRPT+7.63%5.0%
QURE+198.92%4.0%
RGNX+72.74%4.0%
FDMT+196.32%3.0%
MGTX+61.72%2.0%
As of Jul 10, 2026, 7:14 AM ET
Genomics '25: Gene Editing & Genetic Meds Constituents
| Company | Wgt | Premarket % | 1D % | 10D % | MTD % | YTD % | IranWar % | LibDay % | 1Yr % | Mkt Cap |
|---|---|---|---|---|---|---|---|---|---|---|
CRISPR Therapeutics AGCRSP | 14.0% | 0.15% | -4.83% | -0.02% | 1.29% | 7.44% | -6.32% | 64.79% | -4.51% | $5.43B |
Beam Therapeutics Inc.BEAM | 11.0% | 3.82% | -2.87% | 2.49% | 6.99% | 29.22% | 25.86% | 93.83% | 62.60% | $3.69B |
uniQure N.V.QURE | 4.0% | 0.87% | 2.28% | -6.14% | -1.53% | 85.88% | 184.58% | 318.83% | 198.92% | $3.03B |
Sarepta Therapeutics, Inc.SRPT | 5.0% | -0.83% | 1.53% | 20.56% | 12.75% | -4.65% | 22.43% | -67.15% | 7.63% | $2.17B |
Sangamo Therapeutics, Inc.SGMO | 5.0% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $1.80B |
Intellia Therapeutics, Inc.NTLA | 13.0% | 1.07% | -8.31% | -7.04% | -10.44% | 71.75% | 12.05% | 111.51% | 26.97% | $1.73B |
MeiraGTx Holdings plcMGTX | 2.0% | 0.97% | -1.41% | 11.16% | 8.91% | 75.35% | 84.39% | 119.18% | 61.72% | $1.29B |
REGENXBIO Inc.RGNX | 4.0% | -0.54% | 2.76% | 32.29% | 19.56% | 8.68% | 73.12% | 121.99% | 72.74% | $809.1M |
Prime Medicine, Inc.PRME | 9.0% | 0.71% | -8.44% | 13.71% | 8.74% | 21.90% | -8.44% | 136.31% | -9.81% | $764.0M |
4D Molecular Therapeutics, Inc.FDMT | 3.0% | 1.12% | -1.00% | 0.08% | 1.58% | 71.87% | 33.44% | 292.99% | 196.32% | $673.8M |
Verve Therapeutics, Inc.VERV | 8.0% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 60.36% | 0.00% | $560.0M |
Rocket Pharmaceuticals, Inc.RCKT | 6.0% | 0.84% | -1.18% | 24.33% | 19.03% | 19.37% | -16.37% | -33.49% | 32.59% | $457.5M |
Editas Medicine, Inc.EDIT | 5.0% | -1.06% | -10.08% | 3.12% | 0.61% | 60.98% | 50.00% | 179.66% | 7.84% | $323.1M |
Caribou Biosciences, Inc.CRBU | 6.0% | -2.32% | 0.00% | 9.60% | 10.23% | 22.01% | 2.11% | 125.32% | 11.49% | $192.4M |
Metagenomi, Inc. Common StockMGX | 5.0% | 1.19% | -2.33% | 5.00% | 4.13% | -22.22% | -17.11% | -5.26% | -42.99% | $47.4M |
| Theme return | — | 0.59% | -3.30% | 5.33% | 4.64% | 34.47% | 19.32% | 117.14% | 40.38% | — |
| Average | 6.7% | 0.40% | -2.26% | 7.28% | 5.46% | 29.84% | 29.32% | 101.26% | 41.43% | $1.53B |
| Median | 5.0% | 0.71% | -1.18% | 3.12% | 4.13% | 21.90% | 12.05% | 111.51% | 11.49% | $809.1M |
| Std Dev | 3.5% | 1.33% | 3.85% | 10.94% | 7.76% | 33.24% | 51.16% | 104.59% | 68.01% | $1.46B |
| Min | 2.0% | -2.32% | -10.08% | -7.04% | -10.44% | -22.22% | -17.11% | -67.15% | -42.99% | $47.4M |
| Max | 14.0% | 3.82% | 2.76% | 32.29% | 19.56% | 85.88% | 184.58% | 318.83% | 198.92% | $5.43B |
| % Positive Tickers | 60.00% | 20.00% | 66.67% | 73.33% | 73.33% | 60.00% | 73.33% | 66.67% |
About this theme
Genomics '25: Gene Editing & Genetic Meds tracks 15 publicly listed stocks in this theme. Sample tickers: BEAM, CRBU, CRSP, EDIT, FDMT, MGTX, MGX, NTLA, PRME, QURE, RCKT, RGNX, and 3 more. Use the table below for the full list.